CP-LC-1067 860798 Octyl 2-methyl-14-((3-(octyloxy)-3-oxopropyl)thio)-6,9-dioxo-7-(2-((3-oxo-3-(tridecyloxy)propyl)thio)ethyl)-17-thia-2,5,8-triazaicosan-20-oate
Manufactured and Distributed under License from Certest Biotec S.L
Compared to industry-leading lipid nanoparticle (LNP) formulations which have a primary biodistribution in the liver, LNPs formulated using the ionizable lipid CP-LC-1067 exhibit targeted lung tissue selectivity.
pKa in formulation = 8.45 (measured by TNS)